Clinical Trial Update: Pharmacological Intervention to Prevent NOAF After TAVR [NA]

View source ↗

Summary

This clinical trial update describes a planned pharmacological intervention to prevent new-onset atrial fibrillation after transcatheter aortic valve replacemen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Pharmacological Intervention to Prevent NOAF After TAVR

Snippet

Sponsor: Shanghai East Hospital | Conditions: Atrial Fibrillation | NA | Status: NOT_YET_RECRUITING